Efficacy, safety, and cost of pomalidomide in relapsed and refractory multiple myeloma

Objectives To investigate the efficacy, safety, and cost of a pomalidomide‐dexamethasone regimen in patients with relapsed and refractory multiple myeloma (RRMM). Methods All patients (n = 63) treated with pomalidomide‐dexamethasone for RRMM in our university hospital between August 2013 and October...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of haematology 2018-05, Vol.100 (5), p.518-525
Hauptverfasser:	Gueneau, Pauline, Chretien, Marie‐Lorraine, Cransac‐Miet, Amelie, Aho, Ludwig Serge, Lafon, Ingrid, Favennec, Camille, Guy, Julien, Caillot, Denis, Boulin, Mathieu
Format:	Artikel
Sprache:	eng
Schlagworte:	Cancer Dexamethasone Intolerance Life Sciences molecular cytogenetics Multiple myeloma Neutropenia Safety socioeconomics and ethics supportive care Survival
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!